{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:20:52Z","timestamp":1789932052604,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020BD014"],"award-info":[{"award-number":["2020BD014"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC2009004"],"award-info":[{"award-number":["2020YFC2009004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2501700"],"award-info":[{"award-number":["2021YFC2501700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874010"],"award-info":[{"award-number":["81874010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biopha.2022.113665","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T12:56:05Z","timestamp":1662987365000},"page":"113665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Single-intraosseous simvastatin injection suppresses cancers via activating CD8+ T cells"],"prefix":"10.1016","volume":"155","author":[{"given":"Wanqiong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2022.113665_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat. Rev. Drug Disco"},{"issue":"3","key":"10.1016\/j.biopha.2022.113665_bib2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of Classic Hodgkin Lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Disco"},{"issue":"4","key":"10.1016\/j.biopha.2022.113665_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2022.113665_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","article-title":"Car T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment","volume":"10","author":"Martinez","year":"2019","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113665_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","article-title":"Engineering Car-T cells for next-generation cancer therapy","volume":"38","author":"Hong","year":"2020","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.biopha.2022.113665_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8 (+) T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"Van der Leun","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2022.113665_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor-reactive CD8 (+) T cell exhaustion by activating the aryl hydrocarbon receptor","volume":"22","author":"Liu","year":"2021","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113665_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cell.2020.04.017","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"181","author":"Li","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2022.113665_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8 (+) T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.biopha.2022.113665_bib10","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.4049\/jimmunol.2000463","article-title":"Combination of fruquintinib and Anti-PD-1 for the treatment of colorectal cancer","volume":"205","author":"Wang","year":"2020","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113665_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.it.2018.08.001","article-title":"Immunomodulation of tumor vessels: it takes two to tango","volume":"39","author":"Johansson-Percival","year":"2018","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113665_bib12","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1038\/s41467-020-18256-4","article-title":"Exhausted CD8 (+) T cells exhibit low and strongly inhibited TCR signaling during chronic LCMV infection","volume":"11","author":"Sandu","year":"2020","journal-title":"Nat. Commun."},{"issue":"32","key":"10.1016\/j.biopha.2022.113665_bib13","doi-asserted-by":"crossref","first-page":"19388","DOI":"10.1073\/pnas.2000970117","article-title":"LRCH1 deficiency enhances LAT signalosome formation and CD8 (+) T cell responses against tumors and pathogens","volume":"117","author":"Liu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.biopha.2022.113665_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021385118","article-title":"Mitochondrial metabolism is essential for invariant natural killer T cell development and function","volume":"118","author":"Weng","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2022.113665_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000507931","article-title":"Activation, deficiency, and reduced IFN-gamma production of mucosal-associated invariant T cells in patients with inflammatory bowel disease","volume":"12","author":"Ju","year":"2020","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.biopha.2022.113665_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fendo.2017.00354","article-title":"Editorial: bone: endocrine target and organ","volume":"8","author":"Brunetti","year":"2017","journal-title":"Front Endocrinol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113665_bib17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6812","key":"10.1016\/j.biopha.2022.113665_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/35046196","article-title":"Bone versus immune system","volume":"408","author":"Arron","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113665_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/ajplegacy.1922.62.1.1","volume":"62","author":"Drinker","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113665_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.CIR.76.3.534","article-title":"New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase","volume":"76","author":"Tobert","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.113665_bib21","first-page":"191","article-title":"OTC simvastatin supply\u2014what changes in practice and education do pharmacists want?","volume":"273","author":"Blenkinsopp","year":"2004","journal-title":"Pharm. J."},{"key":"10.1016\/j.biopha.2022.113665_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tranon.2020.100867","article-title":"Single-dose local intraosseous injection of simvastatin suppresses breast cancer with tumor vascular normalization","volume":"13","author":"Yuan","year":"2020","journal-title":"Transl. Oncol."},{"issue":"20","key":"10.1016\/j.biopha.2022.113665_bib23","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1158\/0008-5472.CAN-13-3132","article-title":"Cytokine-like molecule CCDC134 contributes to CD8(+) T-cell effector functions in cancer immunotherapy","volume":"74","author":"Huang","year":"2014","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.biopha.2022.113665_bib24","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2022.113665_bib25","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.biopha.2022.113665_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113665_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8 + T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2022.113665_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Disco"},{"issue":"3","key":"10.1016\/j.biopha.2022.113665_bib29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/nu13030809","article-title":"Vitamin K and D supplementation and bone health in chronic kidney disease-apart or together?","volume":"13","author":"Ziemi\u0144ska","year":"2021","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.biopha.2022.113665_bib30","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1681\/ASN.2014020166","article-title":"Reduced renal calcium excretion in the absence of sclerostin expression: evidence for a novel calcium-regulating bone kidney axis","volume":"25","author":"Kumar","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.113665_bib31","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-12-0489","article-title":"Novel aspects of mevalonate pathway inhibitors as antitumor agents","volume":"18","author":"Thurnher","year":"2012","journal-title":"Clin. Cancer Res"},{"issue":"4","key":"10.1016\/j.biopha.2022.113665_bib32","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","article-title":"The Mevalonate pathway is a druggable target for vaccine adjuvant discovery","volume":"175","author":"Xia","year":"2018","journal-title":"Cell"},{"issue":"47","key":"10.1016\/j.biopha.2022.113665_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201802372","article-title":"Remodeling tumor-associated macrophages and neovascularization overcomes EGFR(T790M)-associated drug resistance by PD-L1 nanobody-mediated codelivery","volume":"14","author":"Yin","year":"2018","journal-title":"Small"},{"issue":"14","key":"10.1016\/j.biopha.2022.113665_bib34","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.7150\/thno.42234","article-title":"BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biopha.2022.113665_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7150\/thno.27246","article-title":"Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin beta3\/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery","volume":"9","author":"Jin","year":"2019","journal-title":"Theranostics"},{"issue":"48","key":"10.1016\/j.biopha.2022.113665_bib36","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1038\/onc.2012.6","article-title":"Targeting tumor cell metabolism with statins","volume":"31","author":"Clendening","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.113665_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660361","article-title":"Transcriptome signature of Vgamma9Vdelta2 T cells treated with phosphoantigens and Notch inhibitor reveals interplay between TCR and Notch signaling pathways","volume":"12","author":"Madhok","year":"2021","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113665_bib38","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/cmi.2015.28","article-title":"The promise of gammadelta T cells and the gammadelta T cell receptor for cancer immunotherapy","volume":"12","author":"Legut","year":"2015","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2022.113665_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120218","article-title":"Chitosan\/gamma-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer","volume":"257","author":"Castro","year":"2020","journal-title":"Biomaterials"},{"issue":"7832","key":"10.1016\/j.biopha.2022.113665_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41586-020-2850-3","article-title":"Cancer immunotherapy via targeted TGF-beta signalling blockade in TH cells","volume":"587","author":"Li","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2022.113665_bib41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1074-7613(01)00155-8","article-title":"The TCR triggering puzzle","volume":"14","author":"van der Merwe","year":"2001","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.biopha.2022.113665_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","article-title":"Regulatory mechanisms in T cell receptor signalling","volume":"18","author":"Gaud","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113665_bib43","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nsmb.3492","article-title":"Encoding optical control in LCK kinase to quantitatively investigate its activity in live cells","volume":"24","author":"Liaunardy-Jopeace","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113665_bib44","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.4049\/jimmunol.179.5.2952","article-title":"CD8+ T cell activation is governed by TCR-peptide\/MHC affinity, not dissociation rate","volume":"179","author":"Tian","year":"2007","journal-title":"J. Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222201054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222201054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:20:42Z","timestamp":1781781642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222201054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":44,"alternative-id":["S075333222201054X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113665","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-intraosseous simvastatin injection suppresses cancers via activating CD8+ T cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113665"}}